ArticleEClinicalMedicine2023

High-flow oxygen therapy versus facemask preoxygenation in anticipated difficult airway management (PREOPTI-DAM): an open-label, single-centre, randomised controlled phase 3 trial.

Mickael Vourc'h et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.